NT_1170x120_1-11-18

Jefferies

Time for drug chains to reclaim beauty category

Time for drug chains to reclaim beauty category

NEW YORK — It is a pivotal juncture for the beauty care category in the drug channel. Retailers and brands need to devise a game plan to wrest the business away from prestige power players. Sales in cosmetics, skin care and grooming are firing on all cylinders — but sadly, not in the mass beauty

Surge in flu lifts sales of OTCs and related products

Surge in flu lifts sales of OTCs and related products

NEW YORK — The escalating number of flu cases nationwide has hoisted sales of over-the-counter medicines and other products that help treat and manage flu symptoms, according to market research firm IRI. In a new report titled “Flu Fury: IRI Pinpoints How Flu Is Impacting U.S. Markets,” IRI spotlights areas hit hard by the spread

Analyst: No ‘kneejerk reaction’ from WBA

Analyst: No ‘kneejerk reaction’ from WBA

A CVS-Aetna merger or not, Walgreens Boots Alliance is zeroed in and making headway on its strategic game plan, according to Jefferies analyst Brian Tanquilut. Following a visit to WBA’s headquarters in Deerfield, Ill., last week by the Jefferies team, Tanquilut reported that the CVS deal didn’t “prompt a kneejerk reaction,” and WBA executives remain

CVS, Aetna set to merge in transformative deal

CVS, Aetna set to merge in transformative deal

WOONSOCKET, R.I. — CVS Health plans to acquire health insurer Aetna for roughly $69 billion in a first-of-its kind deal aimed at fending off challenges in retail and health care. The landmark CVS-Aetna merger deal comes at time when insurers are under pressure to lower medical costs, and retailers are under attack from new competitors,

Analyst: Latest Amazon pharmacy fears overblown

Analyst: Latest Amazon pharmacy fears overblown

NEW YORK — Fears among pharmacy players and investors that e-tail giant Amazon plans to enter the industry may be overblown — at least for the time being, according to Jefferies analyst Brian Tanquilut. Pharmacy stocks, including pharmacy retailers and suppliers, have taken a pounding since the St. Louis Post-Dispatch reported last week that Amazon

Reports: CVS in talks about acquiring Aetna

Reports: CVS in talks about acquiring Aetna

Published reports said Thursday that CVS Health is in negotiations to acquire health insurer Aetna. CVS reportedly will offer more than $200 share, or about $66 billion, to purchase the health benefits giant, according to anonymous sources cited by the Wall Street Journal, which originated the story about a potential CVS-Aetna deal. Bloomberg reported that

Walgreens Boots Alliance sees solid 3Q results

Walgreens Boots Alliance sees solid 3Q results

DEERFIELD, Ill. — Analysts said Walgreens Boots Alliance turned in a solid third quarter and stands to emerge on a positive note from its new deal with Rite Aid Corp. upon the termination of their merger. For the third quarter ended May 31, WBA posted net earnings (GAAP) of $1.16 billion, or $1.07 per diluted

Amazon to acquire Whole Foods Market

Amazon to acquire Whole Foods Market

SEATTLE — Amazon.com Inc. will acquire Whole Foods Market Inc. for $13.7 billion, including debt, in the biggest deal ever for the e-tailer as it continues to encroach on the grocery sector. Amazon will pay $42 a share in cash for the natural food chain, the companies said Friday. Whole Foods cofounder and chief executive

Fred’s poised to be chain drug player

Fred’s poised to be chain drug player

Though Fred’s name came up in the buzz surrounding the Walgreens-Rite Aid merger talks with the FTC, the Southeastern retailer’s move to buy 865 Rite Aid stores for $950 million in cash from Walgreens Boots Alliance (WBA) still was surprising. After all, not even two weeks ago, Fred’s reported poor third-quarter results (including a net

Merlo: Integrated care sets CVS Health apart

Merlo: Integrated care sets CVS Health apart

NEW YORK — CVS Health’s integrated pharmacy care model makes it a “partner of choice” in the health care arena, president and chief executive officer Larry Merlo said at the company’s annual Analyst Day event in Manhattan. Merlo and senior CVS Health executives gathered in New York on Thursday to give the investment community an

Rite Aid turns in net loss for first quarter

Rite Aid turns in net loss for first quarter

CAMP HILL, Pa. — Rite Aid Corp. cited pressure in pharmacy reimbursement as it reported a net loss and fell short of Wall Street’s earnings forecast for its fiscal 2017 first quarter. Meanwhile, overall retail sales and same-store sales edged up for the quarter, and the EnvisionRx pharmacy benefit management business, acquired about a year